Please login to the form below

Not currently logged in
Email:
Password:

IQVIA

This page shows the latest IQVIA news and features for those working in and with pharma, biotech and healthcare.

PMEA 2019: Recognising excellence in improving patient outcomes

PMEA 2019: Recognising excellence in improving patient outcomes

Takeda also won in three other categories: Excellence in Collaboration and Partnerships for A Gut Reaction with support from IQVIA, Excellence in Patient Education and Support for NINLARO Patient Support Programme

Latest news

More from news
Approximately 12 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Growing up as a patient is hard to manage Growing up as a patient is hard to manage

    Find out more about these potential solutions by visiting www.iqvia.com or emailing clare.moloney@iqvia.com to request a copy of our recent White Paper: ‘Growing up as a ... Clare Moloney is Programme Insights and Design Lead, Medical and Patient

  • Novel endpoints in the digital age Novel endpoints in the digital age

    Industry’s desire for greater patient-centricity is driving the change, according to Jean Paty, vice president of patient-centred endpoints at IQVIA. ... A closer look. New technologies are also being used to look at established endpoints in a novel way

  • Rethinking trials: the pros and cons of protocol amendments Rethinking trials: the pros and cons of protocol amendments

    Science and Strategy unit at IQVIA. ... Flexibility. Protocol amendments provide drug developers with the flexibility needed to conduct scientifically robust research, said Jenny Fam, Associate Director, Global Regulatory Affairs, IQVIA.

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    research. IQVIA’s Angela McFarlane was on PME’s Women Leaders list last year, and when asked to nominate some worthy women for this year, she didn’t hesitate to name

  • 25 Women Leaders in UK Healthcare (part 2) 25 Women Leaders in UK Healthcare (part 2)

    Dr Harietta Eleftherochorinou, IQVIA’s senior principal RWE AI and machine learning (ML), is a leading light in applying the techniques to pharma’s commercial challenges, including creating personalising medical treatment.

More from intelligence
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics